PIDD: A Switch Hitter  by Wu, Zhao-Hui et al.
Leading Edge
PreviewsPIDD: A Switch Hitter
Zhao-Hui Wu,1 Angela Mabb,1 and Shigeki Miyamoto1,*
1Department of Pharmacology, University of Wisconsin–Madison, 1300 University Avenue, Madison, WI 53706, USA
*Contact: smiyamot@wisc.edu
DOI: 10.1016/j.cell.2005.11.025
In response to genotoxic stress, the PIDD protein promotes apoptosis downstream of the 
tumor-suppressor protein p53. In this issue of Cell, Janssens et al. (2005) demonstrate that, 
in response to such stress, PIDD forms a nuclear complex that enhances sumoylation of 
NEMO. This modification is important for the activation of the antiapoptotic transcription 
factor NF-κB.When cells are faced with condi-
tions that damage the genetic blue-
print of a cell (genotoxic stress), a 
choice between two major fates—life 
or death—must be made. As this 
decision is crucial, many regulatory 
mechanisms are in place to ensure the 980 Cell 123, December 16, 2005 ©2005 correct choice. The survival response 
is coupled to the induction of cell-
cycle arrest at checkpoints in different 
phases of the cell cycle. This permits 
DNA repair, which may be associated 
with the induction of genes promoting 
cell survival. In contrast, induction of Figure 1. PIDD Integrates Pro- and Antiapoptotic Signaling Pathways
PIDD forms a cytoplasmic “PIDDosome” composed of PIDD, RAIDD, and procaspase-2 to promote 
apoptosis through a mitochondrial death pathway in response to genotoxic stimuli. PIDD also forms 
a nuclear PIDDosome containing RIP1 and NEMO (also known as IKKγ) to promote SUMO-1 attach-
ment on NEMO in response to genotoxic and perhaps other stresses. Nuclear RIP1 is also post-
translationally modified in an undefined manner (denoted by “?”). Following NEMO sumoylation, ATM, 
also activated by genotoxic agents through the induction of DNA damage, such as double-strand 
breaks, stimulates a subsequent NEMO modification cascade. These modifications cause NEMO 
translocation from the nucleus to the cytoplasm, where it causes the displacement of IκB (which gets 
degraded). This leads to the release of free NF-κB in the cytoplasm, which then enters the nucleus 
to induce prosurvival gene transcription.Elsevier Inc.distinct molecular events that culmi-
nate in activation of common cell-death 
pathways mediates cell death. A key 
question is how the cell regulates the 
checks and balances of these com-
plex processes to ensure that healthy 
cells survive and genetically damaged 
cells that might lead to tumor forma-
tion do not. Some proteins can act 
as switches for these opposing cell 
fates. In this issue of Cell, Janssens et 
al. (2005) reveal a new switch in this 
fundamental decision-making process 
called PIDD (p53-induced protein with 
a death domain).
PIDD was originally identified as 
a gene that depended on p53 for its 
expression (Lin et al., 2000). PIDD 
induces cell-cycle arrest and apopto-
sis when overexpressed in p53-defi-
cient human cell lines, suggesting that 
PIDD may act downstream of p53 in 
promoting cell death induced by p53. 
Later, Tinel and Tschopp (2004) dem-
onstrated that PIDD associates with 
RAIDD (RIP-associated ICH-1/ECD3-
homologous protein with a death 
domain) and procaspase-2 to form 
a so-called “PIDDosome” that initi-
ates apoptosis through a mitochon-
drial-dependent pathway (Tinel and 
Tschopp, 2004). In their new study, 
Janssens et al. (2005) demonstrate 
that PIDD is important for activating 
an antiapoptotic pathway involving the 
transcription factor NF-κB in response 
to genotoxic stress.
When a cell is exposed to a DNA-
damaging agent, the transcription 
factor NF-κB often turns on cell-sur-
vival genes. Previous studies identified 
multiple important upstream events in 
NF-κB signal transduction pathways 
induced by several DNA-damaging 
agents. An important molecule down-
stream of DNA damage is ATM (ataxia 
telangiectasia mutated), a nuclear 
kinase that is required for NF-κB acti-
vation in response to many DNA-dam-
aging agents, particularly those that 
induce DNA double-strand breaks 
(Huang et al., 2003; Li et al., 2001). 
ATM is also important for the regulation 
of cell-cycle checkpoints, DNA repair, 
and apoptosis in the face of double-
strand breaks (Bakkenist and Kastan, 
2004). Another pivotal upstream event 
is a posttranslational modification 
of NEMO (NF-κB essential modula-
tor) by SUMO-1 (small ubiquitin-like 
modifier 1) (Huang et al., 2003). This 
modification is independent of ATM. 
Sumoylation of NEMO induces a sub-
sequent cascade of events, most nota-
bly phosphorylation and ubiquitination 
of NEMO itself (both modifications are 
ATM dependent). These modifications 
cause the translocation of NEMO from 
the nucleus into the cytoplasm, where 
it causes the release of NF-κB from an 
inhibitory complex in the cytoplasm 
(Huang et al., 2003). This in turn allows 
NF-κB to enter the nucleus and turn 
on genes important for cell survival 
(see Figure 1).
In an in vitro assembly assay using 
cell extracts derived from cultured cells 
stably overexpressing PIDD, Janssens, 
Tinel, and colleagues (2005) found 
that PIDD formed a separate complex 
that contained RIP1 (receptor-interact-
ing protein 1) and NEMO and lacked 
RAIDD and procaspase-2. Both RIP1 
and NEMO are critical players in the 
signaling pathways that lead to acti-
vation of the transcription factor NF-
κB by several DNA-damaging agents 
(Huang et al., 2003; Hur et al., 2003). 
Thus, the authors decided to investi-
gate whether PIDD also modulated 
this activation pathway. Indeed, PIDD 
overexpression promoted phosphory-
lation of IκBα (inhibitor of NF-κB α). 
This phosphorylation event is essential 
for the dissociation of IκBα from NF-
κB and the translocation of NF-κB into 
the nucleus. Therefore, PIDD overex-
pression promotes NF-κB-dependent 
transcription in response to genotoxic 
agents, such as etoposide. Silencing of endogenous PIDD by small interfering 
RNAs (siRNAs) reduced NF-κB activa-
tion by etoposide, thus corroborating 
the overexpression results. This is an 
exciting turn of events, given that NF-
κB activation is linked to tumor forma-
tion and the resistance of human can-
cers to chemotherapy and radiation 
treatment (Karin and Greten, 2005). 
Understanding how PIDD regulates 
this pathway may provide insights 
into the development of future drugs 
against cancer.
Janssens et al. (2005) found that 
PIDD intersected the NF-κB signal-
ing pathway at the step of NEMO 
sumoylation. PIDD overexpression was 
associated with increased detection of 
sumoylated NEMO and augmentation 
of subsequent NEMO phosphoryla-
tion and ubiquitination events. These 
modifications were diminished when 
PIDD levels in cells were reduced 
(using specific siRNAs to target PIDD 
transcripts for degradation). Further-
more, both the association of PIDD 
with NEMO and NEMO modifica-
tions were absent in human leukemic 
cells lacking RIP1. This indicates that 
RIP1 is necessary for these events to 
take place. Coimmunoprecipitation 
experiments demonstrated that PIDD 
associates with RIP1 and unmodified 
NEMO in vitro; however, in vivo, PIDD 
selectively associates with sumoylated 
NEMO and RIP1. Surprisingly, unmod-
ified NEMO was not found in the PIDD 
complex in extracts isolated from cells 
treated with DNA-damaging agents. 
Moreover, PIDD undergoes nuclear 
translocation in response to geno-
toxic stress, whereas NEMO and RIP1 
remain in both the cytoplasm and 
nucleus before and after DNA dam-
age. Given that sumoylated NEMO 
was only found in the nucleus follow-
ing DNA damage, the PIDD-RIP1-
sumoylated NEMO complex appears 
to reside exclusively in the nucleus 
(see Figure 1).
The introduction of PIDD into the 
NEMO sumoylation pathway by Jans-
sens et al. (2005) raises a number 
of interesting questions. First, how 
does PIDD increase the amount of 
sumoylated NEMO in the nucleus? As 
PIDD does not seem to contain motifs 
present in known SUMO ligases, it Cell 123, Decdoes not appear to be a direct SUMO 
ligase for NEMO. Thus, PIDD may 
enhance the interaction between 
NEMO and a SUMO ligase to pro-
mote the sumoylation reaction. This 
analysis awaits the identification of the 
SUMO ligase for NEMO. Alternatively, 
the absence of unmodified NEMO in 
the PIDD complex in vivo suggests 
that PIDD may associate selectively 
with the SUMO-1-modified form of 
NEMO in the nucleus and may pro-
tect it from attack by a protease that 
mediates SUMO removal (the SUMO 
protease for NEMO also remains to 
be identified). This also touches upon 
the question regarding the mecha-
nism of assembly of the PIDD-RIP1-
sumoylated NEMO complex in vivo. Is 
the complex formed in the cytoplasm 
and then imported into the nucleus, 
or do all of the components enter into 
the nucleus separately and then form a 
complex? In either case, the possibility 
that PIDD prevents desumoylation of 
SUMO-modified NEMO is of particu-
lar interest, given that the steady-state 
levels of many sumoylated proteins 
(with the exception of Ran-GAP1, the 
first SUMO target identified) are much 
lower than expected (Hay, 2005). In 
this context, it will be interesting to 
determine whether the capacity of 
PIDD to increase sumoylation is limited 
only to NEMO or whether there are 
multiple PIDDosomes containing dif-
ferent sumoylated proteins that partici-
pate in different molecular pathways.
The question also arises whether 
DNA damage per se is necessary to 
induce the assembly of the nuclear 
PIDDosome or whether some other 
stress (such as oxidative stress that is 
also induced by the genotoxic agents) 
is causing formation of PIDDosomes. 
Given that PIDD promotes cell death 
by forming a separate PIDDosome 
with RAIDD and procaspase-2, pre-
sumably in the cytoplasm (see Figure 
1), how does PIDD know which type 
of PIDDosome to associate with under 
different conditions? Cell-free assem-
bly assays indicate that the PIDD-
RIP1-NEMO complex forms earlier 
than the PIDD-RAIDD-procaspase-2 
complex in vitro. However, elucidation 
of the regulatory mechanisms involved 
in the assembly of these distinct com-ember 16, 2005 ©2005 Elsevier Inc. 981
plexes in vivo may differ depending on 
the cellular setting. Another point that 
requires further investigation is where 
ATM fits into this pathway. Janssens et 
al. (2005) imply that ATM acts down-
stream of the PIDD-RIP1-NEMO PID-
Dosome; however, a previous study 
has shown that ATM is necessary for 
the association of RIP1 with NEMO 
(Hur et al., 2003). Additionally, given 
that NF-κB acts primarily as an anti-
apoptotic factor but also can serve 
as a proapoptotic factor, depending 
on cellular conditions and the DNA-
damaging agents used (Campbell et 
al., 2004), the PIDD-RIP1-sumoylated 982 Cell 123, December 16, 2005 ©2005
In one of the great pioneering experi-
ments in the field of developmental biol-
ogy, Hans Spemann divided amphib-
ian embryos at the two-cell stage 
into separate halves by ligation with a 
human baby’s hair and then monitored 
the ability of the two halves to generate 
a complete amphibian body plan (dis-
cussed in English in Spemann [1938]). 
If the embryos were separated along 
the typical plane of cleavage, which 
separates the left and right sides of the 
embryo, two fully formed twins devel-
oped. Remarkably, however, if two-cell 
frog embryos were split perpendicular 
to the typical cleavage plane result-
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In a famous experiment over 
have a remarkable ability to
of Cell, Reversade and De R
demonstrate that interaction
inhibitors on both the dorsal a
creating the body plan.NEMO complex may act as an inducer 
of apoptosis, depending on the cellu-
lar conditions. Answers to these ques-
tions may provide clues to how PIDD 
acts as a molecular switch to turn life 
and death pathways on and off in the 
face of genetic damage in different 
cellular environments.
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learned about the mechanisms that 
pattern the early amphibian embryo. 
Soon after fertilization, a “dorsalizing 
activity” moves from the bottom of 
the embryo toward one side, which 
will become the future dorsal-anterior 
pole. By default, the opposite side 
will become the ventral-posterior pole 
(for simplicity, these will be referred 
to as the dorsal and ventral poles of 
the embryo). The dorsalizing activity 
locally stabilizes β-catenin, the Wnt 
intracellular signal transducer, which 
subsequently activates genes involved 
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